Search Results
10
Everything
Search Filters
Tag
Medtech
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
March 25, 2025 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a global medical technology innovator, will feature its expanding portfolio of foot and ankle solutions at this year’s...
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
March 24, 2025 07:30 ET
|
Spectral AI, Inc.
DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging...
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
March 24, 2025 07:00 ET
|
Lungpacer Medical USA Inc.
Lungpacer Medical Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience as CCO
York University and ventureLAB strengthen partnership with renewed Memorandum of Understanding
March 20, 2025 12:01 ET
|
York University
Toronto, March 20, 2025 (GLOBE NEWSWIRE) -- York University and ventureLAB signed a renewed Memorandum of Understanding (MoU) to expand their collaboration in talent development, research, and...
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
March 18, 2025 09:00 ET
|
Femasys Inc.
-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first globally to be granted rights to commercialize FemBloc® -- ATLANTA, March 18, 2025 (GLOBE NEWSWIRE)...
OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants
March 17, 2025 10:32 ET
|
ORGANOX LIMITED
OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants
Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System
March 17, 2025 07:00 ET
|
Spectral AI, Inc.
DeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performanceSpectral AI plans...
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
March 13, 2025 08:30 ET
|
Femasys Inc.
ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of...
Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035
March 11, 2025 19:30 ET
|
FACT.MR
Rockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a...
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
March 10, 2025 07:00 ET
|
Lungpacer Medical USA Inc.
Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.